tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc Income Statement

Last quarter (Q3 2024), Janux Therapeutics Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Janux Therapeutics Inc's net income was $-28.06M. See Janux Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 8.08M$ 8.61M$ 3.64M$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -71.02M$ -66.25M$ -32.73M$ -6.57M$ -3.77M
Operating Income
$ -72.98M$ -67.09M$ -32.93M$ -4.84M$ -3.77M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -58.29M$ -63.06M$ -32.67M$ -6.78M$ -4.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis